Dexmedetomidine Hydrochloride Nasal Drops(Visum Pharma)

盐酸右美托咪定滴鼻液(华益泰康药业)

Report date: 2025/08/07 16:22:59

Base Information

Drug NameDexmedetomidine Hydrochloride Nasal Drops(Visum Pharma)
Drug Alias NameDEX-TD盐酸右美托咪啶DEX-SL右美托咪定Dexmedetomidinum +[8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsSedationHypnosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesVisum Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSedationHypnosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A